Pharma-Bio Serv (PBSV) Treasury Shares (2014 - 2026)

Pharma-Bio Serv (PBSV) has reported Treasury Shares for 12 consecutive years, with $581676.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares rose 2.94% year-over-year to $581676.0; the trailing twelve-month figure through Apr 2026 stood at $581676.0 (up 2.94% YoY), and the FY2025 full-year result was $579286.0, up 5.74% from the prior year.
• Treasury Shares steadied at $581676.0 in Q2 2026 per PBSV's latest filing, from $580967.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $617980.0 in Q2 2026 and bottomed at $484329.0 in Q1 2022.
• Historically, Treasury Shares has averaged $552305.8 across 5 years, with a median of $553618.5 in 2024.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares climbed 26.78% in 2022, then gained 0.75% in 2025.
• Over 5 years, Treasury Shares stood at $502236.0 in 2022, then grew by 6.84% to $536580.0 in 2023, then grew by 2.1% to $547843.0 in 2024, then rose by 5.74% to $579286.0 in 2025, then climbed by 0.41% to $581676.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $581676.0, $580967.0, and $579286.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.